Panc 02.03(人胰腺腺癌細(xì)胞)
CBP60681
                       
                         詢  價(jià)
                        
                        
                索取STR
                        
                    產(chǎn)品描述
                    產(chǎn)品數(shù)據(jù)庫(kù)
                    
                | I. General information | |
| Synonyms: | Panc 02.03 | 
| Background: | Panc 02.03 is a pancreatic adenocarcinoma epithelial cell line derived in 1995 from a primary tumor removed from the head-of-the-pancreas of a female with pancreatic adenocarcinoma. | 
| Species: | Homo sapiens, human | 
| Tissue: | pancreas | 
| Disease: | adenocarcinoma | 
| Gender: | White, female, 70 years | 
| Morphology: | epithelial | 
| Growth Mode: | adherent | 
| Doubling Time: | 28.2 hrs | 
| DNA Profile: | Amelogenin: X CSF1PO: 11,12 D13S317: 12 D16S539: 11 D5S818: 12,13 D7S820: 9,10 THO1: 6 TPOX: 9,12 vWA: 17 Our Cell Line Authentication Service  | 
		
| Culture Medium: | 
				 RPMI-1640+15%FBS+10ug/ml insulin Panc 02.03完全培養(yǎng)基,# CBP60681M  | 
		
| Cryopreservation medium: | 90%FBS+10%DMSO | 
| Antigen Expression: | MHC class I +; MHC class II -,Ref | 
| Oncogene: | K-ras + Ref | 
| Genes Expressed: | cytokeratins 7 and 18, Ref | 
| Cellular Products: | cytokeratins 7 and 18, Ref | 
| Tumor Formation: | Yes, forms tumors in nude or SCID mice,Ref | 
| Comments: | The cell line exhibits a K-ras oncogene mutation at codon 12 where a GGT --> GAT mutation resulted in substitution of aspartic acid for glycine. The cells have a reported plating efficiency of 100% For more information, please contact us (4008-750-250).  |